# Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

> **NCT00814619** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 68 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** panitumumab
- **DRUG:** capecitabine
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** 3-dimensional conformal radiation therapy

## Key facts

- **NCT ID:** NCT00814619
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-05
- **Final completion:** 2014-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814619, "Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00814619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*